A retrospective case series identified nine patients who developed ophthalmic complications during treatment with semaglutide ...
Reports link GLP-1 medications like Ozempic and Mounjaro to vision loss, prompting concerns over their safety.
Almost 2% of the U.S. population received prescriptions for the weight-loss and diabetes drugs semaglutide and tirzepatide in ...
Scientists remain puzzled as to why some individuals taking popular weight loss and diabetes medications such as Ozempic and ...
PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...
Yes, rare cases of vision issues have arisen in people taking popular GLP-1 weight loss drugs, but the jury's out on w ...
A small percentage of patients taking the extraordinarily popular GLP-1 medications have experienced vision problems, but a ...
Popular GLP-1 medications like semaglutide and tirzepatide have been linked to rare vision issues, including NAION, raising ...
A small percentage have had vision problems, but a direct causal link with the drugs has not been established.
Researchers looked at the nine people who had vision problems while using the drugs and is one of several that have ...